Rate My Professor Alexandra Tickle

At Otago Innovation, Dr. Tickle supports University of Otago researchers in commercialising discoveries, particularly those advancing health and wellbeing for people and animals. She has played key roles in projects spanning biotechnology, therapeutics, and medical devices, including facilitating first sales for 3D bio-printing technology in 2018 and supporting Proof of Concept grant winners. Notably, she helped negotiate a $14 million investment for spin-out Amaroq Therapeutics. Her contributions earned her a finalist spot in the Commercialisation Professional category of the 2021 KiwiNet Research Commercialisation Awards, as highlighted in the University of Otago Annual Report 2021. Dr. Tickle serves on the KiwiNet Emerging Innovator and Pipeline Committees and provides governance for start-up companies, health-related charities, and animal welfare groups. She holds directorships at Clutha Health First Trust since 2017, Periomedic since 2021, and Amaroq Therapeutics since 2021. Recently, she commented on the promise of ketamine-based treatments for depression emerging from Otago research. Residing on a lifestyle farm in Taieri Beach with her family and rescue animals, Dr. Tickle embodies her commitment to impactful science.